Abstract
Caffeoylxanthiazonoside (CYT) is an active constituent isolated from the fruit of the Xanthium strumarium L plant. The aim of the present study was to investigate the cardioprotective effects of oral administration of CYT on chronic heart failure (CHF) and its underlying mechanisms. A rat model of CHF was first established, and cardiac function indices, including the heart/body weight index, left heart/body weight index, fractional shortening (FS), ejection fraction (EF), cardiac output (CO) and heart rate (HR), were subsequently determined by cardiac ultrasound. Serum levels of lactate dehydrogenase (LDH) and creatine kinase (CK), and the levels of pro-inflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β in heart tissues and cardiac microvascular endothelial cells (CMECs) were determined using ELISA. In addition, the protein expression levels of nuclear factor-κB (NF-κB) signaling pathway members were determined by western blotting in CMECs. The results demonstrated that oral administration of 10, 20, 40 mg/kg CYT significantly reduced cardiac hypertrophy and reversed FS, EF, CO and HR when compared with CHF model rats. In addition, CYT administration significantly decreased the levels ...Continue Reading
References
Sep 17, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Guo-Qing ZhuWei Wang
Aug 16, 2005·Autonomic Neuroscience : Basic & Clinical·Han-Jun WangGuo-Qing Zhu
Dec 31, 2005·Journal of Cardiovascular Pharmacology and Therapeutics·Pirouz ParangRohit Arora
Mar 25, 2006·Fitoterapia·Luping QinHanchen Zheng
Jul 21, 2006·The New England Journal of Medicine·Theophilus E OwanMargaret M Redfield
Mar 14, 2007·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·T HanL-P Qin
Dec 15, 2010·Advances in Experimental Medicine and Biology·Irene GarciaBernhard Ryffel
Nov 23, 2012·Immunopharmacology and Immunotoxicology·Chang-Liang HeBen-Dong Fu
Jan 23, 2013·Pharmaceutical Biology·Cheng YangQiong You
Apr 27, 2013·Journal of Ethnopharmacology·Lu XingGuoan Luo
Jun 12, 2013·Journal of the American College of Cardiology·Xinli LiUNKNOWN Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group
Oct 8, 2013·PloS One·Fangfang ChenYansheng Zhang
Mar 13, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Wei PengLu-Ping Qin
Apr 17, 2014·International Immunopharmacology·Qinghai ShiJianfeng Fu
May 17, 2014·Lancet·Gerd HeuschLionel Opie
Jun 26, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Anzhou XiaWeidong Zhou
Aug 28, 2014·Journal of Chromatography. a·Na GuoYan Lei
Apr 8, 2015·Biomedical Chromatography : BMC·Yanqi HanGuoan Luo
May 9, 2015·BioMed Research International·Sachin L BadoleSubhash L Bodhankar
Jun 10, 2015·PloS One·Xuan YuanChang-gui Li
Jul 30, 2015·European Journal of Heart Failure·Hiroaki ShimokawaYasuhiko Sakata
Apr 19, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Meng GuWen-Juan Tu
May 14, 2016·International Journal of Molecular Medicine·Tianxin HuAidong Wen
Jun 21, 2016·International Journal of Cardiology·M Marcinkiewicz-SiemionK A Kaminski
Citations
Jan 24, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wenxiang FanChunjie Wu
Aug 7, 2019·Journal of Cardiovascular and Thoracic Research·Mahdiyar Iravani SaadiRamin Yaghoobi
Aug 3, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Yanping TangHuzhi Cai